期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 21, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/ijms21041283
关键词
Cannabinoid; oxidative stress; inflammation; agonist WIN 55,212-2; hypoxia ischemia; fetal lambs
资金
- UNIVERSITY OF THE BASQUE COUNTRY-UPV/EHU [GIU 17/018]
- EITB Maratoia-BIOEF [BIO18/IC/003]
- BASQUE GOVERNMENT [POS_2013_1_191, IT773-13]
In the process of neonatal encephalopathy, oxidative stress and neuroinflammation have a prominent role after perinatal asphyxia. With the exception of therapeutic hypothermia, no therapeutic interventions are available in the clinical setting to target either the oxidative stress or inflammation, despite the high prevalence of neurological sequelae of this devastating condition. The endocannabinoid system (ECS), recently recognized as a widespread neuromodulatory system, plays an important role in the development of the central nervous system (CNS). This study aims to evaluate the potential effect of the cannabinoid (CB) agonist WIN 55,212-2 (WIN) on reactive oxygen species (ROS) and early inflammatory cytokine production after hypoxia-ischemia (HI) in fetal lambs. Hypoxic-ischemic animals were subjected to 60 min of HI by partial occlusion of the umbilical cord. A group of lambs received a single dose of 0.01 mu g/kg WIN, whereas non-asphyctic animals served as controls. WIN reduced the widespread and notorious increase in inflammatory markers tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta and IL-6 induced by HI, a modulatory effect not observed for oxidative stress. Our study suggests that treatment with a low dose of WIN can alter the profile of pro-inflammatory cytokines 3 h after HI.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据